InvestorsHub Logo
Followers 0
Posts 127
Boards Moderated 0
Alias Born 04/21/2011

Re: antihama post# 1796

Friday, 09/29/2017 2:22:16 AM

Friday, September 29, 2017 2:22:16 AM

Post# of 3283
We are experiencing a re-evaluation (hope this is the right word in english, in German wie say "Neubewertung") right now. If poziotinib keeps it's efficiacy promises we will see USD 20 next year....

Still hanging on to my expectations i posted on the Yahoo Message Board 10 days ago:

"absolutely best case (only if the data is showing real "breakthrough):
Sep 27th (before abstract release): 11.20
Oct 17th: $13.63
Oct 19th (with updated "breakthrough" data): $18.12

If market expections are dissapointed -> see you well below $10"